Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer
NCT01660360
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Metastatic Cancer
Interventions
BIOLOGICAL:
Tanibirumab
Sponsor
PharmAbcine